Cantel Medical — Merger or Acquisition (July 2019)
17 slides from Cantel Medical's merger presentation, Jul 30, 2019

Slide 1: Cantel's Acquisition of Hu-Friedy
Cantel’s Acquisition of Hu-FriedyJULY 2019

Slide 2: Forward-Looking Statements
This presentation contains “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in Section 27A of the Securi

Slide 3: Creating a Global Leader in Infection Prevention and Reprocessing Workflow Solutions
Accelerates Cantel’s strategy to be a leading global provider of innovative infection prevention and reprocessing workflow solutions and education in both medical and dentalCreates a comprehensive portfolio of infection prevention consumables, instrumentation and instrument management solutionsEnhan

Slide 4: Transaction Details
Transaction Details Total cash, stock and earnout consideration of up to $775M, or $675M net of anticipatedtax benefit$725M upfront: up to $60M in Cantel stock and remainder in cashUp to $50M in contingent consideration based on achievement of certain commercial milestones in the first eighteen mont

Slide 5: Hu-Friedy at a Glance
Hu-Friedy at a Glance Note: LTM as of 05/31 Leading global manufacturer of a comprehensive portfolio of high-quality dental instruments and proprietary Instrument Management SystemPremium dental brand built over 111 years from the student to the dental practitionerHeadquartered in Chicago with ~1,00

Slide 6: Hu-Friedy Product Portfolio
HU-FRIEDY INSTRUMENT MANAGEMENT SYSTEM (IMS) Single-use products used to prevent cross- contamination in dental suites DENTAL INFECTION CONTROL CONSUMABLES Hu-Friedy Product PortfolioA Reputation for Product Excellence With A Cornerstone of Workflow Management Solutions EDUCATION | TRAINING | CUSTOM

Slide 7: Hu-Friedy Instrument Management System (IMS)
Hu-Friedy Instrument Management System (IMS)Proprietary Instrument Reprocessing Workflow Management System Standardizes and combines instrument cleaning, sterilization, storage and organization in one integrated cassette system and processEnables movement of instruments from cleaning through chairsi

Slide 8: Cantel + Hu-Friedy
Cantel + Hu-Friedy Creates a comprehensive portfolio of infection prevention consumables, instrumentation and instrument management solutions to deliver protection, performance and productivity to dental practitionersOne-stop supplier of consumables, instruments and workflow solutions to provide com

Slide 9: A Significant Synergy Opportunity
A Significant Synergy Opportunity Improved scale of combined organization Sourcing savings Manufacturing improvements Key account relationships Cantel product pull-through in Hu-Friedy IMS offering Compelling infection prevention offering Cost Synergies$10m+ annual cost synergies by Year 3 Growth Ac

Slide 10: Compelling Shareholder Value Creation
Compelling Shareholder Value Creation Transforms Cantel’s scale in dental industryProvides significantly improved platform to support revenue growth in mid to high single digits over medium termEnhances competitive position via scale, broad branded portfolio and key relationships with dental schools

Slide 11: Creating a Global Leader in Infection Prevention and Reprocessing Workflow Solutions
Accelerates Cantel’s strategy to be a leading global provider of innovative infection prevention and reprocessing workflow solutions and education in both medical and dentalCreates a comprehensive portfolio of infection prevention consumables, instrumentation and instrument management solutionsEnhan

Slide 12: Non-GAAP Financial Measures Cantel Medical
GAAP to Non-GAAP Disclosure 12 Non-GAAP Financial Measures Cantel MedicalIn evaluating our operating performance, we supplement the reporting of our financial information determined under generally accepted accounting principles in the United States (“GAAP”) with certain non-GAAP financial measures

Slide 13: (continued) Non-GAAP Financial Measures Cantel Medical
GAAP to Non-GAAP Disclosure (continued) 13 Non-GAAP Financial Measures Cantel MedicalAcquisition-related items consist of (i) fair value adjustments to contingent consideration and other contingent liabilities resulting from acquisitions, (ii) due diligence, integration, legal fees and other transac

Slide 14: (continued) Non-GAAP Financial Measures: EBITDAS and Adjusted EBITDAS
GAAP to Non-GAAP Disclosure (continued) 14 Non-GAAP Financial MeasuresEBITDAS and Adjusted EBITDASWe believe EBITDAS is an important valuation measurement for management and investors given the increasing effect that non-cash charges, such as stock-based compensation, amortization related to acquisi

Slide 15: Reconciliation of Net Income to EBITDAS and Adjusted EBITDAS
GAAP to Non-GAAP Disclosure (continued) 15 The reconciliations of net income to EBITDAS and Adjusted EBITDAS were calculated as follows for Cantel Medical: (1) Excludes stock-based compensation expenseLTM = Last Twelve Months LTM 4/30/2019 (amounts in millions) (unaudited) Net income, as reported $

Slide 16: (continued) Non-GAAP Financial Measures Hu-Friedy
GAAP to Non-GAAP Disclosure (continued) 16 Non-GAAP Financial MeasuresHu-FriedyIn evaluating Hu-Friedy’s historical operating performance, Cantel Medical has supplemented the reporting of Hu- Friedy’s financial information determined under generally accepted accounting principles in the United State

Slide 17: Reconciliation of Net Income to EBITDA and Adjusted EBITDA for Hu-Friedy
GAAP to Non-GAAP Disclosure (continued) 17 (1) Restructuring-related costs and other non-recurring adjustments incurred by Hu-Friedy that are not expected to be incurred post-acquisition as a result of respective synergies that are expected to be realized. The reconciliations of net income to EBITDA
Source: SEC EDGAR · 8-K filed Jul 30, 2019
More decks from Cantel Medical Corp
Merger or Acquisition (January 2021)16 slides · Jan 12, 2021
Investor Presentation (December 2020)32 slides · Dec 10, 2020
Investor Presentation (January 2020)31 slides · Jan 9, 2020
Investor Presentation (March 2019)34 slides · Mar 22, 2019
Investor Presentation (January 2016)31 slides · Jan 14, 2016
Investor Presentation (April 2015)28 slides · Apr 30, 2015